Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis

Journal of Clinical Apheresis

Volumn 16, Issue 2, 2001, Pages 74-81

  Hidaka, Toshihiko ^a   Suzuki, Kimihiro ^a   Kawakami, Makoto ^a   Okada, Makoto ^a   Kataharada, Kouji ^a   Shinohara, Tadashi ^a   Takamizawa Matsumoto, Mitsuyo ^a   Ohsuzu, Fumitaka ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Cytokines; Extracorporeal filtration leukocytapheresis; Rheumatoid arthritis; Serum; Synovial fluid

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD FILTRATION; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTAPHERESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FILTRATION LEUKOCYTAPHERESIS; HUMAN; LEUKAPHERESIS; MALE; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; TREATMENT OUTCOME;

ADULT; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; FILTRATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKINS; LEUKAPHERESIS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; RANTES; SYNOVIAL FLUID; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034926637     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.1016     Document Type: Article

References (41)

1. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis
2. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum
3. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis
4. Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis
5. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritis
6. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
7. Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense
8. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis
9. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis
10. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions
11. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin-2 and interleukin-3) and presence of macrophage colony-stimulating factor in rheumatoid synovitis
12. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis
13. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts
14. RANTES role in rheumatoid arthritis
15. Leukocyte depletion of red cell units at the bedside by transfusion through a new fiber
16. Filtration leukocytapheresis therapy in rheumatoid arthritis; a randomized, double blind, placebo-controlled trial
17. + T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
20. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
21. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset
22. CD4+ T cell inducible immunoregulatory cytokine response in rheumatoid arthritis
23. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells
24. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI
25. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
26. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
27. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis
28. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis
29. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis
30. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer
31. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane
32. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis
33. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis
34. Soluble IL-15 receptor a - Chain administration prevents murine collagen-induced arthritis: A role for IL-15 in development of antigen-induced immunopathology
35. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis
36. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
37. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
38. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice
39. Selective attraction of monocytes and T lymphocytes of the memory phenotype by the cytokine RANTES
40. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model
41. Therapeutic criteria in rheumatoid arthritis